Genomic Expression

Genomic Expression

Develops personalized cancer diagnostics/medicine

Other | United States of America | Disease Specific Prevention and Mitigation |

 Profile Provided By: Company Website

Overview

Genomic Expression is finding the best drug for the patient and the best patient for the drug by sequencing RNA. Analyzing RNA is able to tell if the tumor will respond to the new immune therapies which is the only kind of therapy that is a potential cure. We entered into a strategic relationship with IBM to provide our analytics in a HIPAA compliment environment. Genomic Expression started as the diagnostic partner in the $32M Danish Genome Denmark project and we have subsequent developed our platform with the goal of improving outcomes for cancer patients. Jesper Zeuthen CMO worked his whole carrier on curing cancer and he is the co founder of GenMap DanDrit (immune therapy) and Topotarget. We attracted Tanya Kanigan COO she invented OpenArray and brought it into the diagnostic market prior to selling her company to Life Tech and Morten Middelfart CIO who played with Big Data his whole life started his first company at 14 and sold it at 21 Morten Middelfart is building our backend bioinformatics in collaboration with IBM. Morten Pedersen Co and co founder with PhD in genetics and inventor of our sample prep technologies. Gitte has advised the Danish Government on attracting investments to Denmark and done $1B in 6 years and prior to that she was marketing manager at Novo Nordisk.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters


Beverly, Massachusetts United States of America



Explore

Revision History

Last Update: Nov 17, 2017 1:00 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2019 IMPACTSPACE. ALL RIGHTS RESERVED.